Doctor Care Anywhere Group PLC · ASX:DOC
Doctor Care Anywhere — FY2023 Earnings Presentation
14 slides from Doctor Care Anywhere's earnings presentation, Feb 29, 2024
Slide 1: FY23 Preliminary Results
Doctor Care For personal use only Anywhere Transforming lives through better healthcare FY23 Preliminary Results 29 February 2024 1 © 2023 Doctor Care Anywhere
Slide 2: Important Notice and Disclaimer
Important Notice and Disclaimer This presentation is for information purposes only and it is not indicated. A number of figures, amounts, percentages, estimates, performance cannot be relied upon as a guide to future financial product or investment advice. The presentation is not calculations of val
Slide 3: DCA is one of the UK's largest private providers of telehealth services
DCA is one of the UK’s largest private providers of telehealth services We work with health insurers, healthcare providers and corporate customers to connect patients to a range of digitally enabled telehealth services on our proprietary platform Appointments with GPs and ANPs Referrals – diagnostic
Slide 4: Multi-channel Distribution of Our Services
Multi-channel Distribution of Our Services We use a successful B2B2C delivery model and partnerships through multiple channels to deliver services to corporate clients and members Insurers Health providers Employee engagement platforms Direct relationships For personal use only Serving 1,500+ organi
Slide 5: 2023 Executive Summary
2023 Executive Summary FY23 highlights 19% increase • Launch of Mixed Clinical Workforce, with Advanced in consultations on Nurse Practitioners live on platform from June 2023, helping to address capacity constraints and reduce FY22; totalling cost to serve For personal use only 731,000 • Gross marg
Slide 6: FY23 Results Overview
FY23 Results Overview £38.5m 730,600 535,000 For personal use only Revenue(A$72.6m) consultations delivered consultations delivered to returning patients +31% on FY22 +19% on FY22 Demonstrating quality and retention value of service EBITDA loss 46.0% reduced to Gross Profit Margin Up 4ppt on FY22, s
Slide 7: Key Metric Overview
Key Metric Overview For personal use only Consultations by quarter Revenue by quarter (£m’s)* *. All revenue figures exclude GP2U Returning patients New patients Activated Lives by quarter (000’s) Returning patient percentage FY23 7 © 2024 Doctor Care Anywhere
Slide 8: Profit and loss
Profit and loss £ in millions FY23 FY22 Variance % 2H 23 1H 23 Variance % Utilisation revenue 36.0 27.1 8.9 32.8% 18.1 17.9 0.3 1.4% Subscription revenue 2.5 2.2 0.3 12.1% 1.2 1.3 (0.1) (8.0%) Revenue 38.5 29.3 9.1 31.2% 19.3 19.2 0.1 0.8% Cost of sales (20.8) (17.0) (3.8) (22.2%) (10.0) (10.8) 0.9
Slide 9: FY23 financial performance analysis
FY23 financial performance analysis Revenue growth in year Revenue for FY23 was £38.5 million (A$72.6 million), up 31.2% on FY22 • Growth driven by increase in consultations and annual price increases Improvement in gross margin and contribution margin For personal use only Gross profit margin for F
Slide 10: Cash flow vs. EBITDA
Cash flow vs. EBITDA • Operating cash outflow has historically tracked EBITDA on a half yearly basis • 1H 22 and 2H 22: Cost base reduced driven by restructuring exercise with associated one-off costs in 1H, leading to improved results in 2H For personal use only • Both operating cashflow and EBITDA
Slide 11: Balance sheet
Balance sheet £ in thousands FY23 FY22 Variance % Property, plant and equipment 747 1,220 (473) (38.8%) Intangible assets 5,968 9,131 (3,163) (34.6%) Interest in joint venture - 1,966 (1,966) (100.0%) • Intangible assets down by £1.9m due to sale of Investments 1,300 GP2U in year, with £1.3m investm
Slide 12: Market guidance update
Market guidance update • The Company achieved all market guidance targets for 2023 and is on track for EBITDA breakeven in Q1 2024 Metric FY23 guidance Status Annualised revenue run rate 1H23 end £42-46m Met For personal use only Gross margin 50-55% by 2H23 end Met Contribution margin 35%-40% by 2H2
Slide 13: FY24: Look ahead
FY24: Look ahead Balance sheet strengthened • The recently issued £10.6m convertible loan note supports the Company’s medium-term growth by enabling it to reinvest its cash resources in the business Continuing improvement in financial performance: market guidance1 • Positive EBITDA in Q1 2024 For pe
Slide 14: For personal use only
For personal use only doctor care anywhere.
Doctor Care Anywhere Group — FY2023 Earnings Presentation on 6ix